About Us - GenieBiome Limited | Rejuvenate Your Unique Microbiome With Science

G-NiiB® is the registered trademark of GenieBiome Limited

GenieBiome, a biotechnology spinout from The Chinese University of Hong Kong was founded by world-renowned clinician-scientists and supported by a multidisciplinary team of experts in microbiology, metagenomics, bioinformatics, health problem biomarkers, food technology, clinical trials, IP development and commercialization. For over a decade, our team has pioneered the use of microbiome with evidence-based science to tackle a myriad of health problems, including novel virus, gut problems, overweight and metabolic symptoms, skin irritation and mental health.

Our precision portfolio of G-NiiB includes diagnostic and risk prediction tests, next-generation microbiome precision formula, and precision medicine tailored for the Asian population.

G-NiiB immunity formula developed from the first global novel virus microbiome research findings, and the first in the world microbiome based non-invasive gut problems diagnostic are ready to serve the Asian Chinese population now.

Corporate Purpose, Vision and Mission

G-NiiB® is the registered trademark of GenieBiome Limited

G-NiiB

"G-N" - Empowering the health of "Generation-N" which is our Next Generation by providing personalised microbiome solution

"ii" - Embracing "Innovation and Integrity" as our core values in our scientific discovery

"B" - Targeting the “Biome” of our micro-organisms as potential diagnostics and therapeutics

We have a unique solution to health.

We use our unique metagenomics database to identify novel microbes as diagnostic tools and generate personalised therapy for conditions with unmet needs (Microbiome Precision). We offer tailored-made microbial replacement therapy to restore imbalance in gut microbes to improve health outcomes and prevent diseases.

We pursue infinite innovations that are beyond our imagination, and to achieveimpossible missions. G-NiiB is building the world’s largest microBiome Asian Big data to fulfil our mission to provide evidence based targeted solutions for the health of the Next Generations.

To be the world leader in Asian Microbiota research, G-NiiB’s vision is:

Build the largest microbial dataset in Asia

Develop microbiome-based diagnostics and therapeutics solutions.

Offer precise, reliable, safe and effective solutions to improve health outcomes.

Big data analysis on our exclusive and extensive database reveals that Asian and Chinese populations have unique microbiome profile compared to other ethnicities due to hereditary and environmental factors. As such, the microbiome based application in precision diagnosis and therapy may also be different.
Informed by scientific evidence, G-NiiB aims to broaden the availability of microbiome technologies to naturally restore and improves Asian Chinese health in the most precise manner. To achieve this mission, the research team is building the world’s largest microbiome database on Chinese and Asian populations, and incorporating a proprietary big data and machine learning analytics to microbiome research to improve accuracy and efficiency.

This product is not registered under the Pharmacy and Poisons Ordinance or the Chinese Medicine Ordinance. Any claim made for it has not been subject to evaluation for such registration. This product is not intended to diagnose, treat or prevent any disease.
此產品沒有根據《藥劑業及毒藥條例》或《中醫藥條例》註冊。為此產品作出的任何聲稱亦沒有為進行該等註冊而接受評核。此產品並不供作診斷、治療或預防任何疾病之用。